Stockreport

Legend Biotech Highlights Recent Business Updates at 44th Annual J.P. Morgan Healthcare Conference

Legend Biotech Corporation - American Depositary Shares  (LEGN) 
PDF Exceeded 10,000 patients treated to date with CARVYKTI® (ciltacabtagene autoleucel; cilta-cel)Increased CARVYKTI® manufacturing capacity with the physical expansion of t [Read more]